Archives of Pharmacal Research

, Volume 25, Issue 2, pp 208–213 | Cite as

Transcriptional regulation of the glial cell-specific JC virus by p53

  • Hee-Sun Kim
  • Moon-Sook Woo
Research Articles Biochemistry & Molecular Biology


The human polyomavirus JC virus is the etiologic agent of progressive multifocal leukoenceph-alopathy (PML). As the JC virus early promoter directs cell-specific expression of the viral replication factor large T antigen, transcriptional regulation constitutes a major mechanism of glial tropism in PML. It has been demonstrated that SV40 or JC virus large T antigen interacts with p53 protein and regulates many viral and cellular genes. In this study we found that p53 represses the JC virus early promoter in both glial and nonglial cells. To identify the cis-regula-tory elements responsible for p53-mediated repression, deletional and site-directed mutational analyses were performed. Deletion of the enhancer region diminished p53-mediated transcriptional repression. However, point mutations of several transcription factor binding sites in the basal promoter region did not produce any significant changes. In support of this observation, when the enhancer was fused to a heterologous promoter, p53 reduced the promoter activity about three fold. These results indicate that the enhancer region is important for the repression of JC virus transcription by p53. Furthermore, coexpression of JC virus T antigen with a p53 protein abolished p53-mediated repression of the JC virus early promoter in non-glial cells, but not in glial cells. This finding suggests that T antigen interacts with p53 and regulates JC virus transcription in a cell-specific manner.

Key words

JC virus Progressive multifocal leukoencephalopathy p53 T antigen Transcriptional repression Enhancer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Astrom, K. E., Mancall, E. L., and Richardson, E.P., Progressive multifocal leukoencephalopathy.Brain, 81, 93–111 (1958).PubMedCrossRefGoogle Scholar
  2. Bacellar, H., Munoz, A., Miller, E. N., Cohen, B. A., Besley, D., Selens, O. A., Becker, J. T., and McArther, J. C., Temporal trends in the incidence of HIV-1-related neurological diseases.Neurology, 44, 1892–1900 (1994).PubMedGoogle Scholar
  3. Bargonetti, J., Friedman, P. N., Kern, S. E., Vogelstein, B., and Prives, C., Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.Cell, 65, 1083–1091 (1991).PubMedCrossRefGoogle Scholar
  4. Dobbelstein, M. and Roth, J., The large T antigen of simian virus 40 binds and inactivates p53 but not p73.J. Gen. Virol., 79, 3079–3083 (1998).PubMedGoogle Scholar
  5. El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B., Definition of a consensus binding site for p53.Nature Genet., 1, 45–49 (1992).PubMedCrossRefGoogle Scholar
  6. Henson, J. W., Regulation of the glial-specific JC virus early promoter by the transcription factor Sp1.J. Biol. Chem., 269, 1046–1050 (1994).PubMedGoogle Scholar
  7. Henson, J.W., Saffer, J., and Furneaux, The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain.Ann. Neurol., 32, 72–77 (1992).PubMedCrossRefGoogle Scholar
  8. Henson, J. W., Schnitker, B. L., Lee, T. S., and McAllister, J., Cell-specific activation of the glial-specific JC virus early promoter by large T antigen.J. Biol. Chem., 270, 13240–13245 (1995).PubMedCrossRefGoogle Scholar
  9. Jiang, D., Shrinivasan, A., Lozano, G., and Robbins, P.D., SV40 T antigen abrogates p53-mediated transcriptional activity.Oncogene, 8, 2805–2812 (1993).PubMedGoogle Scholar
  10. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W., Participation of p53 protein in the cellular response to DNA damage.Cancer Res., 51, 6304–6311 (1991).PubMedGoogle Scholar
  11. Kenny, S., Natarajan, V., Strike, D., Jhoury, G., and Salzman, N. P. JC virus enhancer-promoter active in human brain cells.Science, 226, 1337–1339 (1984).CrossRefGoogle Scholar
  12. Kim, H. S., Goncalves, N. M., and Henson, J. W., Glial cell-specific regulation of the JC virus early promoter by large T antigen.J. Virol., 74, 755–763 (2000).PubMedCrossRefGoogle Scholar
  13. Kim, H. S., Yang, C., and Kim, K. S., The cell-specific silencer region of the human dopamine beta-hydroxylase gene contains several negative regulatory elements.J. Neurochem., 71, 41–50 (1998).PubMedCrossRefGoogle Scholar
  14. Levine A. J., The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses.Virology, 177 (2), 419–426 (1990).PubMedCrossRefGoogle Scholar
  15. Luckow, B. and Schutz, G., CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.Nucleic Acids Res., 15, 5490 (1987).PubMedCrossRefGoogle Scholar
  16. Mack, D. H., Vartikar, J., Pipas, J. M., and Laimins, L. A. Specific repression of TATA-mediated but not initiator-mediated transcription by wild type p53.Nature, 363, 281–283 (1993).PubMedCrossRefGoogle Scholar
  17. Major, E. O., Amemiya, K., Tomatore, C. S., Houff, S. A., and Berger, J.R., Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelination disease of the human brain.Clin. Microbiol. Rev., 5, 49–73 (1992).PubMedGoogle Scholar
  18. Rencic, A., Gordon, J., Otte, J., Curtis, M., Kovatich, A., Zoltick, P., Khalili, K., and Andrew, D., Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastro-cytoma.,Proc. Natl. Acad. Sci. USA, 93, 7352–7357 (1996).PubMedCrossRefGoogle Scholar
  19. Staib, C., Pesch, J., Gerwig, R., Gerber, J. -K., Brehn, U., Stangl, A., and Grummt, F., p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large T-antigen.Virology, 219, 237–246 (1996).PubMedCrossRefGoogle Scholar
  20. Weber, T and Major E.O., Progressive multifocal leukoence-phalopathy: molecular biology, pathogenesis and clinical impact.Intervirol., 40, 98–111 (1997).CrossRefGoogle Scholar
  21. Werness, B. A., Levine, A. J., and Howley, P. M., Association of human papillomavirus types 16 and 18 E6 proteins with p53.Science, 248(4951), 76–79 (1990).PubMedCrossRefGoogle Scholar
  22. Zu Rhein, G. M. and Chou, S.-M., Particles resembling papova viruses in human cerebral demyelinating disease.Science, 148, 1477–1479 (1965).CrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2002

Authors and Affiliations

  1. 1.Department of Brain and Neuroscience, Ewha Institute of Neuroscience, College of MedicineEwha Womans UniversityJongno-Gu, SeoulKorea

Personalised recommendations